Evidence map›Paper›PMID 21888508›Full record

ReviewAnnual review of physiology2012

Nuclear sphingolipid metabolism.

Natasha C Lucki, Marion B Sewer

Abstract readReview
In one paragraph

Review in Annual review of physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. SF-1 Induces Nuclear PIP2.Biomolecules · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.Advances in experimental medicine and biology · 2022
    Article
  18. Article
  19. Nuclear sphingomyelin in neurodegenerative diseases.Neural regeneration research · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Natasha C LuckiSchool of Biology, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.
Marion B Sewer
Georgia Institute of Technology · USUniversity of California, San Diego · US

Funding

Nuclear Lipids in SteroidogenesisR01DK084178 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SEWER, MARION B. · 2010 to 2014
$1.4M
NIDDK NIH HHS R01 DK084178
6 · The paper itself

Abstract

Nuclear lipid metabolism is implicated in various processes, including transcription, splicing, and DNA repair. Sphingolipids play roles in numerous cellular functions, and an emerging body of literature has identified roles for these lipid mediators in distinct nuclear processes. Different sphingolipid species are localized in various subnuclear domains, including chromatin, the nuclear matrix, and the nuclear envelope, where sphingolipids exert specific regulatory and structural functions. Sphingomyelin, the most abundant nuclear sphingolipid, plays both structural and regulatory roles in chromatin assembly and dynamics in addition to being an integral component of the nuclear matrix. Sphingosine-1-phosphate modulates histone acetylation, sphingosine is a ligand for steroidogenic factor 1, and nuclear accumulation of ceramide has been implicated in apoptosis. Finally, nuclear membrane-associated ganglioside GM1 plays a pivotal role in Ca(2+) homeostasis. This review highlights research on the factors that control nuclear sphingolipid metabolism and summarizes the roles of these lipids in various nuclear processes.

Indexed as

AnimalsCalciumCell NucleusCeramidesGangliosidesG(M1) GangliosideHomeostasisHumansLysophospholipidsSphingolipidsSphingomyelinsSphingosineCalciumceramide 1-phosphateCeramidesGangliosidesG(M1) GangliosideLysophospholipidsSphingolipidsSphingomyelinsSphingosinesphingosine 1-phosphate

Identifiers

PMID21888508
PMCPMC3981831
OpenAlexW2124041203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.